Global Information
회사소개 | 문의 | 위시리스트

세계의 금 나노입자 시장 : 성장, 동향, 예측(2019-2024년)

Gold Nanoparticles Market - Growth, Trends, and Forecast (2019 - 2024)

리서치사 Mordor Intelligence LLP
발행일 2019년 05월 상품 코드 854082
페이지 정보 영문
가격
US $ 4,250 ₩ 5,110,000 PDF by E-mail (Single User License)
US $ 4,750 ₩ 5,711,000 PDF by E-mail (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,215,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 9,018,000 PDF by E-mail (Corporate License)


세계의 금 나노입자 시장 : 성장, 동향, 예측(2019-2024년) Gold Nanoparticles Market - Growth, Trends, and Forecast (2019 - 2024)
발행일 : 2019년 05월 페이지 정보 : 영문

세계의 금 나노입자 시장은 2019-2014년의 예측기간 중 10% 이상의 CAGR로 성장할 것으로 예상됩니다. 시장 성장을 촉진하고 있는 주요 요인에는 의료 업계에서의 나노테크놀러지 용도 확대와 하이엔드 일렉트로닉스 분야로부터의 수요 확대가 있습니다.

세계의 금 나노입자(Gold Nanoparticles) 시장에 대해 조사 분석했으며, 시장 개요, 시장 역학, 시장 세분화, 지역별 시장 분석, 경쟁 상황, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사 가정
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 성장 촉진요인
    • 의료 산업에서 나노테크놀러지 용도의 확대
    • 하이엔드 일렉트로닉스 부문으로부터의 수요 증가
  • 성장 저해요인
    • 금 가격의 변동
    • 기타
  • 업계 밸류체인 분석
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 소비자의 협상력
    • 신규 참여업체의 위협
    • 대체 제품 및 서비스의 위협
    • 경쟁 정도

제5장 시장 세분화

  • 용도별
    • 이미징
    • 표적화된 약물전달
    • 센서
    • 체외진단약
    • 프로브
    • 촉매작용
    • 기타
  • 최종 이용 산업별
    • 일렉트로닉스
    • 헬스케어
    • 화학제품
    • 기타 최종 이용 산업
  • 지역별
    • 아시아태평양
    • 북미
    • 유럽
    • 남미
    • 중동 및 아프리카

제6장 경쟁 상황

  • M&A, 합작투자, 협업, 계약
  • 시장 점유율 분석
  • 주요 기업의 채용 전략
  • 기업 개요
    • Apollo Biolife
    • Aurion
    • BBI Solutions.
    • Cline Scientific
    • Cytodiagnostics Inc.
    • Cytodiagnostics Inc.
    • Expedeon Ltd
    • Meliorum Technologies Inc.
    • Merck KGaA
    • Nanocomposix.eu.
    • NanoHybrids
    • NANOPARTZ INC.
    • TANAKA HOLDINGS Co., Ltd.

제7장 시장 기회 및 향후 동향

  • 일렉트로닉스 분야의 혁신
  • 기타 기회
KSM 19.06.14

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Market Overview

The global gold nanoparticles market is expected to record a CAGR of over 10% during the forecast period of 2019-2024. The major factors driving the market studied are rising nanotechnology applications in the medical industry and rising demand from the high-end electronics sector.

  • Volatility in the price of gold is expected to hinder the growth of the market studied.
  • Innovation in the field of electronics is likely to act as an opportunity for the market studied during the forecast period.

Key Market Trends

Targeted Drug Delivery is the Major Application

  • Targeted drug delivery segment represents one of the largest application bases for the gold nanoparticles market.
  • Target drug delivery system is an advanced form of drug delivery system where the medication drug or a pharmacologically active agent is selectively delivered by the nanoparticles at an exact corresponding site of action or absorption, and not to the non-target organs, tissues, or cells.
  • Introduction of nanoparticles to the targeted drug delivery system has resulted in various benefits, such as high therapeutic efficacy, high targeting efficiency, and reproducibility.
  • Gold nanoparticles are used to deliver multiple drugs molecules, vaccines, recombinant proteins, or nucleotides into their targets, and can also control the volume of drug released via biological stimuli (internal) or light activation (external).
  • One of the other advantages of using gold nanoparticles is that its surface can be modified using some specialty polymers, such as polyethylene glycol (PEG). This is expected to result in increasing the stability of gold nanoparticles in different physiological conditions and provide a multiformity of combinations on gold nanoparticles. This is further expected to boost the usage of gols nanoparticles in treated drug delivery application.

United States to Dominate the North America Market

  • The medical technology industry continues to be one of the most vital and dynamic sectors of the US economy and a leading force in the revolution that is transforming America's health care system. The country's medical technology industry is among the world leaders in producing state-of-the-art lifesaving and life-enhancing products. Fueled by huge research & development investments, the medical technology industry sets a standard on all relevant measures of growth - employment trends, production values, exports, global market share, venture capital financing.
  • About 35% - 40% of the total domestic medical device production is exported, and a similar share of the United States' domestic consumption is imported. Overseas sales account for approximately 40% - 50% of the overall revenues for US medical device companies, including the foreign subsidiaries revenue.
  • A major chunk of the United States' medical device market traditionally came from the EU and Japan. However, the rising medical investments in the developing countries, like China and India, is now creating a larger scope for the development of the US medical technology market.
  • The breakthroughs in areas, such as device miniaturization and nanotechnology, has created vast opportunities for the growth of the gold nanoparticles market in the United States.
  • Owing to the rapid pace of innovation in the advancement of technology and R&D activities in the electronics industry, there is a high demand for newer and faster electronic products. There is a spur in the number of manufacturing plants and development centers in the United States that are focusing on high-end products, which is expected to boost the demand for gold nanoparticles over the forecast period.
  • Hence, due to the aforementioned factors, the market for gold nanoparticles in the United States is expected to witness high growth over the forecast period.

Competitive Landscape

The global gold nanoparticles market is fragmented in nature. The major companies include NANOPARTZ INC., BBI Solutions., TANAKA HOLDINGS Co., Ltd., Nanocomposix.eu., and Cytodiagnostics Inc., among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Rising Nanotechnology Applications in the Medical Industry
    • 4.1.2 Rising Demand from the High-end Electronics Sector
  • 4.2 Restraints
    • 4.2.1 Volatility in Price of Gold
    • 4.2.2 Other Restraints
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porters 5 Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Application
    • 5.1.1 Imaging
    • 5.1.2 Targeted Drug Delivery
    • 5.1.3 Sensors
    • 5.1.4 In Vitro Diagnostics
    • 5.1.5 Probes
    • 5.1.6 Catalysis
    • 5.1.7 Other Applications
  • 5.2 End-user Industry
    • 5.2.1 Electronics
    • 5.2.2 Healthcare
    • 5.2.3 Chemicals
    • 5.2.4 Other End-user Industries
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 Italy
      • 5.3.3.4 France
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle East & Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share Analysis**
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Apollo Biolife
    • 6.4.2 Aurion
    • 6.4.3 BBI Solutions.
    • 6.4.4 Cline Scientific
    • 6.4.5 Cytodiagnostics Inc.
    • 6.4.6 Cytodiagnostics Inc.
    • 6.4.7 Expedeon Ltd
    • 6.4.8 Meliorum Technologies Inc.
    • 6.4.9 Merck KGaA
    • 6.4.10 Nanocomposix.eu.
    • 6.4.11 NanoHybrids
    • 6.4.12 NANOPARTZ INC.
    • 6.4.13 TANAKA HOLDINGS Co., Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Innovation in the Field of Electronics
  • 7.2 Other Opportunities
Back to Top
전화 문의
F A Q